{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:45:33Z","timestamp":1768837533574,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00277-024-05772-2","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T07:01:55Z","timestamp":1714028515000},"page":"2059-2072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia"],"prefix":"10.1007","volume":"103","author":[{"given":"Kumiyo","family":"Tazoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8585-1450","authenticated-orcid":false,"given":"Naonori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Makuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhito","family":"Takakuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asao","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutaka","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"issue":"1","key":"5772_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000489702","volume":"86","author":"RP Hasserjian","year":"2019","unstructured":"Hasserjian RP (2019) Myelodysplastic Syndrome Updated. Pathobiology 86(1):7\u201313. https:\/\/doi.org\/10.1159\/000489702","journal-title":"Pathobiology"},{"issue":"9936","key":"5772_CR2","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/s0140-6736(13)61901-7","volume":"383","author":"L Ad\u00e8s","year":"2014","unstructured":"Ad\u00e8s L, Itzykson R, Fenaux P (2014) Myelodysplastic syndromes. Lancet 383(9936):2239\u20132252. https:\/\/doi.org\/10.1016\/s0140-6736(13)61901-7","journal-title":"Lancet"},{"issue":"8","key":"5772_CR3","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/acr.20504","volume":"63","author":"A de Hollanda","year":"2011","unstructured":"de Hollanda A, Beucher A, Henrion D, Ghali A, Lavigne C, L\u00e9vesque H, Hamidou M, Subra JF, Ifrah N, Belizna C (2011) Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res (Hoboken) 63(8):1188\u20131194. https:\/\/doi.org\/10.1002\/acr.20504","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"5772_CR4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/rheumatology\/keh136","volume":"43","author":"S Giannouli","year":"2004","unstructured":"Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM (2004) Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatol (Oxford) 43(5):626\u2013632. https:\/\/doi.org\/10.1093\/rheumatology\/keh136","journal-title":"Rheumatol (Oxford)"},{"issue":"2","key":"5772_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/rheumatology\/kev294","volume":"55","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N, Kahn J-E, Hamidou M, Park S, Pu\u00e9chal X, Toussirot E, Falgarone G, Launay D, Morel N, Trouiller S, Mathian A, Gombert B, Schoindre Y, Lioger B, De Wazieres B, Amoura Z, Buchdaul A-L, Georgin-Lavialle S, Dion J, Madaule S, Raffray L, Cathebras P, Piette JC, Rose C, Ziza JM, Lortholary O, Montestruc F, Omouri M, Denis G, Rossignol J, Nimubona S, Ad\u00e8s L, Gardin C, Fenaux P, Fain O (2015) Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology 55(2):291\u2013300. https:\/\/doi.org\/10.1093\/rheumatology\/kev294","journal-title":"Rheumatology"},{"issue":"5","key":"5772_CR6","doi-asserted-by":"publisher","first-page":"E280","DOI":"10.1002\/ajh.24333","volume":"91","author":"RS Komrokji","year":"2016","unstructured":"Komrokji RS, Kulasekararaj A, Al Ali NH, Kordasti S, Bart-Smith E, Craig BM, Padron E, Zhang L, Lancet JE, Pinilla-Ibarz J, List AF, Mufti GJ, Epling-Burnette PK (2016) Autoimmune diseases and myelodysplastic syndromes. Am J Hematol 91(5):E280-283. https:\/\/doi.org\/10.1002\/ajh.24333","journal-title":"Am J Hematol"},{"key":"5772_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MD.0000000000025406","volume":"100","author":"Y Arinobu","year":"2021","unstructured":"Arinobu Y, Kashiwado Y, Miyawaki K, Ayano M, Kimoto Y, Mitoma H, Akahoshi M, Miyamoto T, Horiuchi T, Akashi K, Niiro H (2021) Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis. Medicine 100:3. https:\/\/doi.org\/10.1097\/MD.0000000000025406","journal-title":"Medicine"},{"issue":"16","key":"5772_CR8","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1200\/jco.2015.65.0515","volume":"34","author":"BC Shaffer","year":"2016","unstructured":"Shaffer BC, Ahn KW, Hu ZH, Nishihori T, Malone AK, Valc\u00e1rcel D, Grunwald MR, Bacher U, Hamilton B, Kharfan-Dabaja MA, Saad A, Cutler C, Warlick E, Reshef R, Wirk BM, Sabloff M, Fasan O, Gerds A, Marks D, Olsson R, Wood WA, Costa LJ, Miller AM, Cortes J, Daly A, Kindwall-Keller TL, Kamble R, Rizzieri DA, Cahn JY, Gale RP, William B, Litzow M, Wiernik PH, Liesveld J, Savani BN, Vij R, Ustun C, Copelan E, Popat U, Kalaycio M, Maziarz R, Alyea E, Sobecks R, Pavletic S, Tallman M, Saber W (2016) Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome. J Clin Oncol 34(16):1864\u20131871. https:\/\/doi.org\/10.1200\/jco.2015.65.0515","journal-title":"J Clin Oncol"},{"issue":"12","key":"5772_CR9","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilst\u00f6cker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12):2454\u20132465. https:\/\/doi.org\/10.1182\/blood-2012-03-420489","journal-title":"Blood"},{"issue":"20","key":"5772_CR10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"issue":"8","key":"5772_CR11","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912\u20132919. https:\/\/doi.org\/10.1182\/blood-2005-05-2004","journal-title":"Blood"},{"issue":"12","key":"5772_CR12","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M (2009) Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 15(12):1628\u20131633. https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"5772_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","volume":"108","author":"BD Cheson","year":"2006","unstructured":"Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H (2006) Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 108(2):419\u2013425. https:\/\/doi.org\/10.1182\/blood-2005-10-4149","journal-title":"Blood"},{"issue":"2","key":"5772_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000446062","volume":"136","author":"O Wolach","year":"2016","unstructured":"Wolach O, Stone R (2016) Autoimmunity and Inflammation in Myelodysplastic Syndromes. Acta Haematol 136(2):108\u2013117. https:\/\/doi.org\/10.1159\/000446062","journal-title":"Acta Haematol"},{"issue":"11","key":"5772_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1080\/1042819021000016186","volume":"43","author":"MW Saif","year":"2002","unstructured":"Saif MW, Hopkins JL, Gore SD (2002) Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 43(11):2083\u20132092. https:\/\/doi.org\/10.1080\/1042819021000016186","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"5772_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1182\/blood-2004-05-2017","volume":"106","author":"EM Sloand","year":"2005","unstructured":"Sloand EM, Mainwaring L, Fuhrer M, Ramkissoon S, Risitano AM, Keyvanafar K, Lu J, Basu A, Barrett AJ, Young NS (2005) Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood 106(3):841\u2013851. https:\/\/doi.org\/10.1182\/blood-2004-05-2017","journal-title":"Blood"},{"issue":"13","key":"5772_CR17","doi-asserted-by":"publisher","first-page":"e3091","DOI":"10.1097\/md.0000000000003091","volume":"95","author":"SJ Lee","year":"2016","unstructured":"Lee SJ, Park JK, Lee EY, Joo SH, Jung KC, Lee EB, Song YW, Yoon SS (2016) Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study. Med (Baltimore) 95(13):e3091. https:\/\/doi.org\/10.1097\/md.0000000000003091","journal-title":"Med (Baltimore)"},{"issue":"3","key":"5772_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"5772_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ejh.12311","volume":"93","author":"JJ Frietsch","year":"2014","unstructured":"Frietsch JJ, Dornaus S, Neumann T, Scholl S, Schmidt V, Kunert C, Sayer HG, Hochhaus A, La Ros\u00e9e P (2014) Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review. Eur J Haematol 93(3):247\u2013259. https:\/\/doi.org\/10.1111\/ejh.12311","journal-title":"Eur J Haematol"},{"issue":"5","key":"5772_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-2141.2011.08683.x","volume":"153","author":"S Aggarwal","year":"2011","unstructured":"Aggarwal S, van de Loosdrecht AA, Alhan C, Ossenkoppele GJ, Westers TM, Bontkes HJ (2011) Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy. Br J Haematol 153(5):568\u2013581. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08683.x","journal-title":"Br J Haematol"},{"issue":"22","key":"5772_CR21","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.3390\/cancers14225656","volume":"14","author":"O Kouroukli","year":"2022","unstructured":"Kouroukli O, Symeonidis A, Foukas P, Maragkou M-K, Kourea EP (2022) Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes. Cancers 14(22):5656","journal-title":"Cancers"},{"issue":"4","key":"5772_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.beha.2004.08.007","volume":"17","author":"GJ Mufti","year":"2004","unstructured":"Mufti GJ (2004) Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 17(4):543\u2013557. https:\/\/doi.org\/10.1016\/j.beha.2004.08.007","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"5772_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.5RI0317-083R","volume":"102","author":"AH Cull","year":"2017","unstructured":"Cull AH, Rauh MJ (2017) Success in bone marrow failure? Novel therapeutic directions based on the immune environment of myelodysplastic syndromes. J Leukoc Biol 102(2):209\u2013219. https:\/\/doi.org\/10.1189\/jlb.5RI0317-083R","journal-title":"J Leukoc Biol"},{"issue":"1","key":"5772_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.htct.2019.12.002","volume":"43","author":"M Boada","year":"2021","unstructured":"Boada M, Echarte L, Guillermo C, Diaz L, Touri\u00f1o C, Grille S (2021) 5-Azacytidine restores interleukin 6-increased production in mesenchymal stromal cells from myelodysplastic patients. Hematol Transfus Cell Ther 43(1):35\u201342. https:\/\/doi.org\/10.1016\/j.htct.2019.12.002","journal-title":"Hematol Transfus Cell Ther"},{"key":"5772_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1172\/jci152673","volume":"132","author":"Y Mei","year":"2022","unstructured":"Mei Y, Ren K, Liu Y, Ma A, Xia Z, Han X, Li E, Tariq H, Bao H, Xie X, Zou C, Zhang D, Li Z, Dong L, Verma A, Lu X, Abaza Y, Altman JK, Sukhanova M, Yang J, Ji P (2022) Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia. J Clin Invest 132:17. https:\/\/doi.org\/10.1172\/jci152673","journal-title":"J Clin Invest"},{"issue":"1","key":"5772_CR26","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1038\/s41467-020-17942-7","volume":"11","author":"S Valletta","year":"2020","unstructured":"Valletta S, Thomas A, Meng Y, Ren X, Drissen R, Seng\u00fcl H, Di Genua C, Nerlov C (2020) Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGF\u03b21 as regulators of hematopoietic ageing. Nat Commun 11(1):4075. https:\/\/doi.org\/10.1038\/s41467-020-17942-7","journal-title":"Nat Commun"},{"issue":"3\u20134","key":"5772_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/10428190009089441","volume":"37","author":"HJ Deeg","year":"2000","unstructured":"Deeg HJ, Beckham C, Loken MR, Bryant E, Lesnikova M, Shulman HM, Gooley T (2000) Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome. Leuk Lymphoma 37(3\u20134):405\u2013414. https:\/\/doi.org\/10.3109\/10428190009089441","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"5772_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/leu.2011.251","volume":"26","author":"A Pardanani","year":"2012","unstructured":"Pardanani A, Finke C, Lasho TL, Al-Kali A, Begna KH, Hanson CA, Tefferi A (2012) IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes. Leukemia 26(4):693\u2013699. https:\/\/doi.org\/10.1038\/leu.2011.251","journal-title":"Leukemia"},{"issue":"3","key":"5772_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0923-1811(95)00439-4","volume":"11","author":"Y Yamakawa","year":"1996","unstructured":"Yamakawa Y, Sugita Y, Nagatani T, Takahashi S, Yamakawa T, Tanaka S, Nakamura S, Ohno S, Sekihara H, Okuda K, Nakajima H (1996) Interleukin-6 (IL-6) in patients with Beh\u00e7et\u2019s disease. J Dermatol Sci 11(3):189\u2013195. https:\/\/doi.org\/10.1016\/0923-1811(95)00439-4","journal-title":"J Dermatol Sci"},{"issue":"4","key":"5772_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10165-003-0245-6","volume":"13","author":"H Hasegawa","year":"2003","unstructured":"Hasegawa H, Iwamasa K, Hatta N, Fujita S (2003) Beh\u00e7et\u2019s disease associated with myelodysplastic syndrome with elevated levels of inflammatory cytokines. Mod Rheumatol 13(4):350\u2013355. https:\/\/doi.org\/10.1007\/s10165-003-0245-6","journal-title":"Mod Rheumatol"},{"key":"5772_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms222011241","volume":"22","author":"A Marcuzzi","year":"2021","unstructured":"Marcuzzi A, Melloni E, Zauli G, Romani A, Secchiero P, Maximova N, Rimondi E (2021) Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity. Int J Mol Sci 22:20. https:\/\/doi.org\/10.3390\/ijms222011241","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5772_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<138::AID-PATH810>3.0.CO;2-F","volume":"182","author":"LJ Hammond","year":"1997","unstructured":"Hammond LJ, Lowdell MW, Cerrano PG, Goode AW, Bottazzo GF, Mirakian R (1997) Analysis of apoptosis in relation to tissue destruction associated with hashimoto\u2019s autoimmune thyroiditis. J Pathol 182(2):138\u2013144. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199706)182:2%3c138::AID-PATH810%3e3.0.CO;2-F","journal-title":"J Pathol"},{"key":"5772_CR33","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3389\/fimmu.2018.01197","volume":"9","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wu Y, Hou Y, Liu Y, Liu T, Zhang H, Fan C, Guan H, Li Y, Shan Z, Teng W (2018) Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis. Front Immunol 9:1197. https:\/\/doi.org\/10.3389\/fimmu.2018.01197","journal-title":"Front Immunol"},{"issue":"5","key":"5772_CR34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40618-020-01477-1","volume":"44","author":"AP Weetman","year":"2021","unstructured":"Weetman AP (2021) An update on the pathogenesis of Hashimoto\u2019s thyroiditis. J Endocrinol Invest 44(5):883\u2013890. https:\/\/doi.org\/10.1007\/s40618-020-01477-1","journal-title":"J Endocrinol Invest"},{"issue":"Suppl 1","key":"5772_CR35","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1053\/j.seminhematol.2013.03.018","volume":"50","author":"T Nishimoto","year":"2013","unstructured":"Nishimoto T, Kuwana M (2013) CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia. Semin Hematol 50(Suppl 1):S43-49. https:\/\/doi.org\/10.1053\/j.seminhematol.2013.03.018","journal-title":"Semin Hematol"},{"key":"5772_CR36","doi-asserted-by":"publisher","first-page":"155645","DOI":"10.1016\/j.cyto.2021.155645","volume":"146","author":"Y Kaneko","year":"2021","unstructured":"Kaneko Y, Takeuchi T (2021) An update on the pathogenic role of IL-6 in rheumatic diseases. Cytokine 146:155645. https:\/\/doi.org\/10.1016\/j.cyto.2021.155645","journal-title":"Cytokine"},{"issue":"3","key":"5772_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","volume":"29","author":"S Jodele","year":"2015","unstructured":"Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, Goebel J, Dixon BP (2015) A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 29(3):191\u2013204. https:\/\/doi.org\/10.1016\/j.blre.2014.11.001","journal-title":"Blood Rev"},{"issue":"4","key":"5772_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41409-017-0042-z","volume":"53","author":"T Altmann","year":"2018","unstructured":"Altmann T, Slack J, Slatter MA, O\u2019Brien C, Cant A, Thomas M, Brodlie M, Annavarapu S, Gennery AR (2018) Endothelial cell damage in idiopathic pneumonia syndrome. Bone Marrow Transplant 53(4):515\u2013518. https:\/\/doi.org\/10.1038\/s41409-017-0042-z","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"5772_CR39","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 51(7):906\u2013912. https:\/\/doi.org\/10.1038\/bmt.2016.130","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"5772_CR40","doi-asserted-by":"publisher","first-page":"437.e431","DOI":"10.1016\/j.jtct.2021.01.021","volume":"27","author":"N Tanizawa","year":"2021","unstructured":"Tanizawa N, Koh H, Okamura H, Yamamoto K, Makuuchi Y, Kuno M, Takakuwa T, Koh S, Nanno S, Nishimoto M, Hirose A, Nakamae M, Nakashima Y, Nakane T, Hino M, Nakamae H (2021) Risk Factor and Long-Term Outcome Analyses for Acute Limbic Encephalitis and Calcineurin Inhibitor-Induced Encephalopathy in Adults following Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther 27(5):437.e431-437.e439. https:\/\/doi.org\/10.1016\/j.jtct.2021.01.021","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"5772_CR41","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/ped.13064","volume":"58","author":"A Morimoto","year":"2016","unstructured":"Morimoto A, Nakazawa Y, Ishii E (2016) Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management. Pediatr Int 58(9):817\u2013825. https:\/\/doi.org\/10.1111\/ped.13064","journal-title":"Pediatr Int"},{"key":"5772_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/cancers15030680","volume":"15","author":"D Vythoulkas","year":"2023","unstructured":"Vythoulkas D, Tsirigotis P, Griniezaki M, Konstantellos I, Lazana I (2023) Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation. Cancers (Basel) 15:3. https:\/\/doi.org\/10.3390\/cancers15030680","journal-title":"Cancers (Basel)"},{"issue":"7","key":"5772_CR43","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","volume":"53","author":"S Kang","year":"2021","unstructured":"Kang S, Kishimoto T (2021) Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp Mol Med 53(7):1116\u20131123. https:\/\/doi.org\/10.1038\/s12276-021-00649-0","journal-title":"Exp Mol Med"},{"issue":"5","key":"5772_CR44","doi-asserted-by":"publisher","first-page":"C589","DOI":"10.1152\/ajpcell.00235.2017","volume":"314","author":"H Alsaffar","year":"2018","unstructured":"Alsaffar H, Martino N, Garrett JP, Adam AP (2018) Interleukin-6 promotes a sustained loss of endothelial barrier function via Janus kinase-mediated STAT3 phosphorylation and de novo protein synthesis. Am J Physiol Cell Physiol 314(5):C589-c602. https:\/\/doi.org\/10.1152\/ajpcell.00235.2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"5772_CR45","doi-asserted-by":"publisher","first-page":"e14474","DOI":"10.1097\/md.0000000000014474","volume":"98","author":"P Wu","year":"2019","unstructured":"Wu P, Liang W, Chen X, Chen L, Yang X, Yan Z, Wang W (2019) Pretransplant C-reactive protein as a prognostic marker in allogeneic stem cell transplantation: A PRISMA-compliant meta-analysis. Med (Baltimore) 98(8):e14474. https:\/\/doi.org\/10.1097\/md.0000000000014474","journal-title":"Med (Baltimore)"},{"issue":"25","key":"5772_CR46","doi-asserted-by":"publisher","first-page":"e11179","DOI":"10.1097\/md.0000000000011179","volume":"97","author":"C Sun","year":"2018","unstructured":"Sun C, Luo Y, Tong H, Xu G, Lin J (2018) Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review. Medi (Baltimore) 97(25):e11179. https:\/\/doi.org\/10.1097\/md.0000000000011179","journal-title":"Medi (Baltimore)"},{"issue":"27","key":"5772_CR47","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, Balanda N, Ross DL, Ospina Cardona D, Wu Z, Patel B, Manthiram K, Groarke EM, Gutierrez-Rodrigues F, Hoffmann P, Rosenzweig S, Nakabo S, Dillon LW, Hourigan CS, Tsai WL, Gupta S, Carmona-Rivera C, Asmar AJ, Xu L, Oda H, Goodspeed W, Barron KS, Nehrebecky M, Jones A, Laird RS, Deuitch N, Rowczenio D, Rominger E, Wells KV, Lee C-CR, Wang W, Trick M, Mullikin J, Wigerblad G, Brooks S, Dell\u2019Orso S, Deng Z, Chae JJ, Dulau-Florea A, Malicdan MCV, Novacic D, Colbert RA, Kaplan MJ, Gadina M, Savic S, Lachmann HJ, Abu-Asab M, Solomon BD, Retterer K, Gahl WA, Burgess SM, Aksentijevich I, Young NS, Calvo KR, Werner A, Kastner DL, Grayson PC (2020) Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med 383(27):2628\u20132638. https:\/\/doi.org\/10.1056\/NEJMoa2026834","journal-title":"N Engl J Med"},{"issue":"26","key":"5772_CR48","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/blood.2020010177","volume":"137","author":"E Bourbon","year":"2021","unstructured":"Bourbon E, Heiblig M, Gerfaud Valentin M, Barba T, Durel C-A, Lega JC, Barraco F, S\u00e8ve P, Jamilloux Y, Sujobert P (2021) Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood 137(26):3682\u20133684. https:\/\/doi.org\/10.1182\/blood.2020010177","journal-title":"Blood"},{"issue":"2","key":"5772_CR49","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/S2352-3026(23)00375-7","volume":"11","author":"V Lacombe","year":"2024","unstructured":"Lacombe V, Hadjadj J, Georgin-Lavialle S, Lavigne C, Genevi\u00e8ve F, Kosmider O (2024) Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond. Lancet Haematol 11(2):e160\u2013e167. https:\/\/doi.org\/10.1016\/S2352-3026(23)00375-7","journal-title":"Lancet Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05772-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05772-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05772-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:08:22Z","timestamp":1715580502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05772-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["5772"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05772-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by Institutional Review Board of the Osaka Metropolitan University Hospital and performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}